ClinicalTrials.Veeva

Menu

Study on the Application of Saliva EBV-DNA Detection in EBV Infection Related Diseases

Capital Medical University logo

Capital Medical University

Status

Unknown

Conditions

EBV Infection

Treatments

Diagnostic Test: Saliva Testing

Study type

Observational

Funder types

Other

Identifiers

NCT04782674
saliva EBV-DNA

Details and patient eligibility

About

This study is a single-center, prospective, observational clinical study to evaluate the Application of saliva EBV-DNA Detection in EBV Infection Related Diseases

Enrollment

40 estimated patients

Sex

All

Ages

3 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. According to the HLH-04 diagnostic criteria, it meets the HLH diagnostic criteria. EBV infection occurs in cells with EBV-DNA copy number significantly increased in peripheral blood or tissue, or where EBV coding small RNA(EBER) is detected in tissue or peripheral blood. Or Straus' 1988 diagnostic criteria for CAEBV.
  2. Informed consent

Exclusion criteria

  1. Patients who cannot cooperate with saliva collection
  2. Patients who are unwilling to cooperate with the project research according to the project research plan.

Trial contacts and locations

1

Loading...

Central trial contact

Zhao Wang, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems